SG11201601721UA - Molecular diagnostic test for oesophageal cancer - Google Patents
Molecular diagnostic test for oesophageal cancerInfo
- Publication number
- SG11201601721UA SG11201601721UA SG11201601721UA SG11201601721UA SG11201601721UA SG 11201601721U A SG11201601721U A SG 11201601721UA SG 11201601721U A SG11201601721U A SG 11201601721UA SG 11201601721U A SG11201601721U A SG 11201601721UA SG 11201601721U A SG11201601721U A SG 11201601721UA
- Authority
- SG
- Singapore
- Prior art keywords
- diagnostic test
- molecular diagnostic
- oesophageal cancer
- oesophageal
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1316027.0A GB201316027D0 (en) | 2013-09-09 | 2013-09-09 | Molecular diagnostic test for oesophageal cancer |
| PCT/GB2014/052727 WO2015033172A1 (en) | 2013-09-09 | 2014-09-09 | Molecular diagnostic test for oesophageal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601721UA true SG11201601721UA (en) | 2016-04-28 |
Family
ID=49486941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601721UA SG11201601721UA (en) | 2013-09-09 | 2014-09-09 | Molecular diagnostic test for oesophageal cancer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160222460A1 (en) |
| EP (1) | EP3044327A1 (en) |
| JP (1) | JP2016531579A (en) |
| KR (1) | KR20160057416A (en) |
| CN (1) | CN105874080A (en) |
| AU (1) | AU2014316823A1 (en) |
| CA (1) | CA2923527A1 (en) |
| GB (1) | GB201316027D0 (en) |
| IL (1) | IL244471A0 (en) |
| MX (1) | MX2016003077A (en) |
| SG (1) | SG11201601721UA (en) |
| WO (1) | WO2015033172A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014235453A1 (en) | 2013-03-15 | 2015-10-08 | Genentech, Inc. | Biomarkers and methods of treating PD-1 and PD-L1 related conditions |
| US9885721B2 (en) | 2014-05-29 | 2018-02-06 | Spring Bioscience Corporation | PD-L1 antibodies and uses thereof |
| RU2715038C2 (en) | 2014-07-11 | 2020-02-21 | Дженентек, Инк. | Anti-pd-l1 antibodies and methods for their diagnostic use |
| EP3254110B1 (en) | 2015-02-03 | 2020-03-18 | Ventana Medical Systems, Inc. | Histochemical assay for evaluating expression of programmed death ligand 1 (pd-l1) |
| CN105861741B (en) * | 2016-06-24 | 2019-10-01 | 河北医科大学第四医院 | The diagnosis and treatment target of SENP3 gene and its expression product as the cancer of the esophagus |
| CN106520925A (en) * | 2016-10-14 | 2017-03-22 | 浙江大学 | Primer group for detecting esophagus cancer, and detection method |
| CN107680018A (en) * | 2017-09-27 | 2018-02-09 | 杭州铭师堂教育科技发展有限公司 | A kind of college entrance will based on big data and artificial intelligence makes a report on system and method |
| GB201716712D0 (en) * | 2017-10-12 | 2017-11-29 | Inst Of Cancer Research: Royal Cancer Hospital | Prognostic and treatment response predictive method |
| SG11202009696WA (en) * | 2018-04-13 | 2020-10-29 | Freenome Holdings Inc | Machine learning implementation for multi-analyte assay of biological samples |
| CN109295208A (en) * | 2018-10-26 | 2019-02-01 | 德阳市人民医院 | Application of the PI15 as osteoarthritis marker |
| CN110246544B (en) * | 2019-05-17 | 2021-03-19 | 暨南大学 | Biomarker selection method and system based on integration analysis |
| US20220251657A1 (en) * | 2021-01-29 | 2022-08-11 | Board Of Regents, The University Of Texas System | Genomic diagnostic method and kit to diagnose early esophageal cancer and barretts esophagus |
| WO2024097998A1 (en) * | 2022-11-04 | 2024-05-10 | Foundation Medicine, Inc. | Composite immune biomarkers and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6686155B2 (en) * | 2001-06-14 | 2004-02-03 | Response Genetics, Inc. | Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression |
| EP1416964A4 (en) * | 2001-07-09 | 2005-10-12 | Aphton Corp | Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| WO2007084992A2 (en) * | 2006-01-19 | 2007-07-26 | The University Of Chicago | Prognosis and therapy predictive markers and methods of use |
| CA2675370A1 (en) * | 2007-01-18 | 2008-07-24 | University Of Southern California | Gene polymorphisms as sex-specific predictors in cancer therapy |
| WO2010040083A2 (en) * | 2008-10-03 | 2010-04-08 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Gene expression predictors of chemoresistance |
| JP2012517238A (en) * | 2009-02-11 | 2012-08-02 | カリス エムピーアイ インコーポレイテッド | Molecular profiling of tumors |
| US20130236567A1 (en) * | 2010-06-04 | 2013-09-12 | Katherine J. MARTIN | Gene expression signature as a predictor of chemotherapeutic response in breast cancer |
| NZ712823A (en) * | 2010-09-15 | 2017-05-26 | Almac Diagnostics Ltd | Molecular diagnostic test for cancer |
-
2013
- 2013-09-09 GB GBGB1316027.0A patent/GB201316027D0/en not_active Ceased
-
2014
- 2014-09-09 EP EP14766775.2A patent/EP3044327A1/en not_active Withdrawn
- 2014-09-09 MX MX2016003077A patent/MX2016003077A/en unknown
- 2014-09-09 KR KR1020167009346A patent/KR20160057416A/en not_active Application Discontinuation
- 2014-09-09 JP JP2016539638A patent/JP2016531579A/en active Pending
- 2014-09-09 AU AU2014316823A patent/AU2014316823A1/en not_active Abandoned
- 2014-09-09 SG SG11201601721UA patent/SG11201601721UA/en unknown
- 2014-09-09 CN CN201480059197.4A patent/CN105874080A/en active Pending
- 2014-09-09 CA CA2923527A patent/CA2923527A1/en not_active Abandoned
- 2014-09-09 WO PCT/GB2014/052727 patent/WO2015033172A1/en active Application Filing
- 2014-09-09 US US14/917,925 patent/US20160222460A1/en not_active Abandoned
-
2016
- 2016-03-07 IL IL244471A patent/IL244471A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016003077A (en) | 2016-07-21 |
| CA2923527A1 (en) | 2015-03-12 |
| US20160222460A1 (en) | 2016-08-04 |
| WO2015033172A1 (en) | 2015-03-12 |
| IL244471A0 (en) | 2016-04-21 |
| GB201316027D0 (en) | 2013-10-23 |
| EP3044327A1 (en) | 2016-07-20 |
| JP2016531579A (en) | 2016-10-13 |
| CN105874080A (en) | 2016-08-17 |
| AU2014316823A1 (en) | 2016-04-28 |
| KR20160057416A (en) | 2016-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1214633A1 (en) | Molecular diagnostic test for cancer | |
| IL244472A0 (en) | Molecular diagnostic test for lung cancer | |
| IL244471A0 (en) | Molecular diagnostic test for oesophageal cancer | |
| IL229681A0 (en) | Molecular diagnostic test for cancer | |
| GB201409479D0 (en) | Molecular diagnostic test for cancer | |
| GB2521148B (en) | Airflow testing apparatus | |
| ZA201504861B (en) | Apparatus for improved disease detection | |
| PL2839787T3 (en) | Error detection arrangements for surgical instrument assemblies | |
| PL3066456T3 (en) | Inspection apparatus | |
| EP2996564C0 (en) | Medical apparatus | |
| EP2996064B8 (en) | Stationary-type information-code reading apparatus | |
| DK2847355T3 (en) | COLORECTAL CANCER DIAGNOSTIC GENERAL MARKING PANEL | |
| EP3077009A4 (en) | Molecular imaging probes | |
| EP2870499A4 (en) | Diagnostic apparatus | |
| PT3041575T (en) | Medical apparatus | |
| SG11201502499UA (en) | Cancer diagnosis device | |
| GB2521888B (en) | Ultrasound testing | |
| EP3067691A4 (en) | Examination device | |
| GB201401174D0 (en) | pPost raising apparatus | |
| GB201307256D0 (en) | Diagnostic method | |
| GB201403667D0 (en) | Vehicle apparatus | |
| IL245477A0 (en) | Lung cancer diagnosis | |
| PL2862531T3 (en) | Instrument test arrangement | |
| GB201302380D0 (en) | Diagnostic test | |
| HK1203043A1 (en) | Examination instrument |